I like this:
Dr Andy Fischer, CEO Medgate said: "We are absolutely convinced that the use of new technologies like ResAppDx will enable an advancement of our Digital Health platform. This will benefit our patients by enabling them to be treated conclusively by phone or video in even more cases."
I know this is only white noise and fluff, but it still gives me confidence in ResApp's future.
Ann: Medgate commences European ResAppDx trial, page-4
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
